Archean Chemical Industries

Archean Chemical's Q4 FY26 standalone revenue fell 9% YoY to ₹304.7 croreCurrent reported value: 9% YoY to ₹304.7 crore. No comparable prior figure is available in the source record., with EBITDA down 34.3% to ₹66.4 croreCurrent reported value: 34.3% to ₹66.4 crore. No comparable prior figure is available in the source record. and margin at 21.79%Current reported value: 21.79%. No comparable prior figure is available in the source record.. Industrial salt volumes dropped 7.2% to 1.1 million tonsCurrent 1.1 million tons. Reported change: -7.2% YoY. due to customer deferrals from the US-Iran conflict and logistics disruptions from road construction in Kutch, adding ₹14-15Current reported value: 15. No comparable prior figure is available in the source record. crore in extra costs. Bromine volumes recovered to 3,731 tonsCurrent 3,731 tons. Reported change: +4% YoY. (+4% YoY) with realization up 14%, but long-term contract pricing lagged spot. The bromine derivatives business grew 50% YoY but remains at 45% capacity utilization. Management expects logistics normalization by early Q3 FY27 and aims to restore historical margins as external headwinds subside. Key risk: sustained geopolitical tensions could keep commodity and freight costs elevated, delaying margin recovery.